Soleno Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Soleno Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Soleno Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Soleno Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $28M | 407k | 67.60 |
| 2025-03-31 | $2.0M | 27k | 71.45 |
| 2024-12-31 | $1.1M | 24k | 44.95 |
| 2024-09-30 | $703k | 14k | 50.49 |
| 2024-06-30 | $418k | 10k | 40.80 |
| 2024-03-31 | $41k | 948 | 42.80 |
| 2023-12-31 | $27k | 681 | 40.25 |
| 2023-09-30 | $979k | 33k | 29.51 |
| 2023-06-30 | $25 | 6 | 4.33 |
| 2023-03-31 | $150k | 70k | 2.15 |
| 2022-12-31 | $0 | 6 | 0.00 |